Bain Capital Life Sciences Opportunities III, LP

13D and 13G Filings

13D/G filings
13G on 4 securities
CIK
0001950105
All SEC filings
View on sec.gov
Issuer % of Class Filed
Cabaletta Bio, Inc. 13G/A Amendment 3
CABA · 12674W109
9.6% 11/16/2026
Event 9/30/2026
Cabaletta Bio, Inc. 13G/A Amendment 2
CABA · 12674W109
10.0% 8/14/2026
Event 6/30/2026
Kyverna Therapeutics, Inc. 13G/A Amendment 2
KYTX · 501976104
4.8% 8/14/2026
Event 6/30/2026
Kyverna Therapeutics, Inc. 13G/A Amendment 1
KYTX · 501976104
5.4% 2/17/2026
Event 12/31/2025
Century Therapeutics, Inc. 13G/A Amendment 1
IPSC · 15673T100
4.1% 11/14/2025
Event 9/30/2025
Cabaletta Bio, Inc. 13G/A Amendment 1
CABA · 12674W109
10.0% 8/14/2025
Event 6/30/2025
Disc Medicine, Inc. 13G/A Amendment 3
IRON · 254604101
3.3% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.